Sanofi Successfully Prices €1.5 Billion Offering Under Euro Medium Term Note Program

  The offering includes: €850 million floating rate notes, due March 2027, bearing interest at 3-month Eur...

March 6, 2025 | Thursday | News
Novo Nordisk Delivers Strong 2024 Results with 26% Revenue Growth, Fueled by GLP-1 Success and Obesity Market Expansion

Novo Nordisk, a global leader in diabetes and obesity care, reported a stellar performance for the fourth quarter (Q4) a...

February 26, 2025 | Wednesday | Company results
Bristol Myers Squibb Caps 2024 with Strong Q4 Growth, Bolstered by Key Products and Pipeline Advances

“We made good progress in 2024, which was capped by a fourth quarter of strong topline growth driven by key produc...

February 26, 2025 | Wednesday | Analysis
Amgen’s 2024 Revenue Soars 19% Amid Strong Product Sales and Strategic Investments

"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...

February 26, 2025 | Wednesday | Company results
Teva Reports $4.2B Q4 2024 Revenue as Specialty Medicines and Biosimilars Drive Growth

Teva Pharmaceuticals' Q4 2024 results reflect both the challenges and successes of the company as it continues its "Pivo...

February 17, 2025 | Monday | Company results
Takeda Reports Strong Q4 2024 Performance with 9.8% Revenue Growth, Driven by Oncology and Plasma-Derived Therapies

Takeda Pharmaceuticals has released its financial report for the fourth quarter of 2024, showcasing strong financial per...

February 17, 2025 | Monday | Company results
SK Bioscience Reports 73% Revenue Growth in Q4 2024, Driven by IDT Biologika Acquisition and Vaccine Expansionv

SK Bioscience reported strong revenue growth in Q4 2024, primarily driven by the consolidation of IDT Biologika, expansi...

February 17, 2025 | Monday | Company results
Pfizer Reports Strong Q4 2024 with $17.8B Revenue, Driven by Oncology and Cardiovascular Growth

Pfizer reported a strong fourth quarter (Q4) of 2024, achieving $17.8 billion in total revenues, reflecting a 21% year-o...

February 17, 2025 | Monday | Company results
Novartis Reports Strong Q4 2024 with 16% Sales Growth, Driven by Cardiovascular, Oncology, and Immunology Therapies

Novartis delivered a strong Q4 2024 performance, with net sales growing by 16% year-over-year (YoY) at constant currency...

February 17, 2025 | Monday | Company results
Moderna Reports $966M Q4 2024 Revenue Amid COVID-19 Vaccine Decline, Focuses on mRNA Pipeline Expansion

Financial Performance Overview Moderna reported Q4 2024 revenue of $966 million, marking a 66% decline year-over-year (...

February 17, 2025 | Monday | Company results
GSK Reports Strong Q4 2024 Growth in Specialty Medicines and HIV, Offsetting Vaccine Declines

GSK delivered a strong performance in Q4 2024, with total sales reaching £8.12 billion, reflecting a 4% year-over-...

February 17, 2025 | Monday | Company results
Eli Lilly Reports Record Q4 2024 Revenue of $13.53B, Fueled by Mounjaro, Zepbound, and Oncology Growth

Eli Lilly & Co. reported a strong financial performance in Q4 2024, with substantial revenue growth driven by its bl...

February 17, 2025 | Monday | Company results
Biogen Reports Q4 and Full-Year 2024 Results: Strong EPS Growth Amid Revenue Challenges

Key Financial Highlights Biogen Inc. reported its fourth-quarter (Q4) and full-year 2024 results on February 12, 2025. ...

February 17, 2025 | Monday | Company results
AstraZeneca Reports Strong Q4 2024 Growth with $14.89 Billion Revenue, Driven by Oncology and Innovative Therapies

  AstraZeneca delivered a strong performance in Q4 2024, with Total Revenue reaching $14.89 billion, marking a 24%...

February 17, 2025 | Monday | Company results
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing

Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...

September 24, 2024 | Tuesday | News
Aevice Health secures $7M Seed Plus funding to expand remote monitoring for chronic respiratory disease

Aevice Health, a leading provider of remote monitoring solutions for chronic respiratory disease management, has raised ...

August 12, 2024 | Monday | News
Singapore EDB aims to strengthen economic competitiveness by attracting investment

Singapore EDB aims to strengthen Singapore’s competitiveness amidst a rapidly changing external environment, build...

January 30, 2024 | Tuesday | Company results
AbbVie expands Biologics Manufacturing Capacity with $223 M investment at Singapore Site 

AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...

January 25, 2024 | Thursday | Company results

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls